Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques

Korean Journal of Radiology 2017³â 18±Ç 4È£ p.615 ~ p.623

¹ÚÇý¼±(Park Hye-Sun) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology
¹éÁ¤È¯(Baek Jung-Hwan) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology
¹Ú¿Àȯ(Park Auh-Whan) - University of Virginia Health System Department of Radiology
Á¤»õ·Ò(Chung Sae-Rom) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology
ÃÖ¿µÁØ(Choi Young-Jun) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology
ÀÌÁ¤Çö(Lee Jeong-Hyun) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology

Abstract

Radiofrequency ablation (RFA) is a well-known, effective, and safe method for treating benign thyroid nodules and recurrent thyroid cancers. Thyroid-dedicated devices and basic techniques for thyroid RFA were introduced by the Korean Society of Thyroid Radiology (KSThR) in 2012. Thyroid RFA has now been adopted worldwide, with subsequent advances in devices and techniques. To optimize the treatment efficacy and patient safety, understanding the basic and advanced RFA techniques and selecting the optimal treatment strategy are critical. The goal of this review is to therefore provide updates and analysis of current devices and advanced techniques for RFA treatment of benign thyroid nodules and recurrent thyroid cancers.

Å°¿öµå

Radiofrequency ablation, Thyroid nodules, Technique, Ultrasound, Thermal ablation
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Understanding the basic and advanced RFA techniques, and selecting the optimal treatment strategy, are critical to optimize treatment efficacy and patient safety.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå